Delivery Order SPE2DR25D2102-SPE2DR26FB2FW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injectors on September 3, 2025, with a ceiling value of $1,007.21 and an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed price delivery order represents a single-use contract with no set-aside designation. The award is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a $7,096.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside award was competitively procured and represents a small-value transaction within AmerisourceBergen's extensive portfolio of federal pharmaceutical supply contracts. The order will be fulfilled from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,785.41 on June 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by June 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,765.60 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order is set to be completed by December 3, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside contract under a larger indefinite delivery contract (IDC) vehicle. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,405.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,949.83 on December 1, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors valued at $1,383.99 with an ultimate completion date of December 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,875.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 3, 2025, with completion expected by November 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under the contractor's existing Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,313.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a December 10, 2025 completion date. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was executed on December 9, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2FWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,302.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through the DLA's medical supply chain. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, and no set-aside designation was applied, indicating the award resulted from competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a pharmaceutical prime vendor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen maintains an extensive portfolio of medical products and supplies supporting military healthcare globally. The Zepbound order reflects the company's role in supplying specialty medications and brand-name pharmaceuticals across multiple therapeutic domains to support the Department of Defense's medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/23/25 |